Evaluation of the combined effects of doxorubicin and bortezomib on the human acute lymphoblastic leukemia cell line
Increasing numbers of oncological patients and growing drug resistance ensure that new methods of cancer treatment are intensively sought. Combining drugs for a synergistic effect is one of several possible ways to mitigate this problem. This leads to reducing the effective drug dose and the occurre...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2019-06-01
|
Series: | Current Issues in Pharmacy and Medical Sciences |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/cipms.2019.32.issue-2/cipms-2019-0017/cipms-2019-0017.xml?format=INT |